$2.75 -0.08 (%) Corcept Therapeutics Inc - NASDAQ

Sep. 22, 2014 | 04:00 PM

Partner Headlines

  1. Two Stocks for the Value Investor and GAARP Enthusiast

    GuruFocus | Jun. 7, 2014 | 12:54PM EST
  2. Morning Market Losers

    Benzinga | May. 7, 2014 | 09:48AM EST
  3. UPDATE: Stifel Terminates Coverage on Corcept Therapeutics Due to Reallocation of Resources

    Benzinga | Mar. 10, 2014 | 09:40AM EST
  4. UPDATE: Stifel Downgrades Corcept Therapeutics, See Gradual Progress with Korlym

    Benzinga | Jan. 13, 2014 | 08:13AM EST
  5. Corcept Therapeutics Inc. Reports Operating Results (10-Q)

    GuruFocus | Nov. 8, 2012 | 12:06PM EST
  6. UPDATE: Oppenheimer Downgrades Corcept Therapeutics to Perform on Disappointing Sales

    Benzinga | Nov. 2, 2012 | 08:45AM EST
  7. UPDATE: Piper Jaffray Downgrades Corcept Therapeutics to Neutral on Korlym Outlook

    Benzinga | Sep. 13, 2012 | 05:33AM EST
  8. Corcept Therapeutics Inc. Reports Operating Results (10-Q)

    GuruFocus | Aug. 9, 2012 | 13:33PM EST
  9. Equity Moves on Sell-Side Sentiment for July 13, 2012

    Benzinga | Jul. 13, 2012 | 09:11AM EST
  10. UPDATE: Bank of America Initiates Corcept Therapeutics at Underperform on Korlym Launch Caution

    Benzinga | Jul. 13, 2012 | 02:37AM EST
  11. Parametric Technology, Generac Holdings Among Stocks Down on High Volume Monday

    FoxBusiness | Jul. 2, 2012 | 06:32AM EST
  12. UPDATE: Stifel Nicolaus Increases Target to $9 on Concept Therepeutics

    Benzinga | Feb. 21, 2012 | 02:37AM EST
  13. Corcept Therapeutics Pops 61% After Friday's FDA Approval

    Benzinga | Feb. 21, 2012 | 02:13AM EST
  14. Notable Call Options Activity in Corcept Therapeutics

    Benzinga | Jan. 31, 2012 | 07:09AM EST
  15. Notable Put Options Activity in Corcept Therapeutics

    Benzinga | Jan. 5, 2012 | 05:42AM EST
Trading Center